Greer Labs Reports Positive Findings from Large Phase III Clinical Trial Evaluating Sublingual Immunotherapy for Ragweed Allergies
6/12/2012 10:34:01 AM
More...
|
Greer Labs Announces Veterinary Partnership With IDEXX Laboratories, Inc. (IDXX)
5/15/2012 10:37:22 AM
More...
|
Greer Labs Release: Landmark Allergy Study Uncovers Significant Healthcare Savings Associated with Immunotherapy in Children
11/11/2008 9:48:04 AM
More...
|
Greer Labs Completes Enrollment for Pivotal Phase III Clinical Trial Evaluating the Efficacy of Sublingual-Oral Immunotherapy for Treating Short Ragweed Allergies
6/26/2008 9:32:44 AM
More...
|
Greer Labs's Sublingual-Oral Immunotherapy Clinical Trials Supporting the Safety of Home-Administered Treatment Published in the Annals of Allergy, Asthma and Immunology
3/17/2008 9:21:44 AM
More...
|
Greer Launches Phase III Trial to Study Efficacy of Sublingual-Oral Immunotherapy in Patients with Allergic Rhinoconjunctivitis
3/14/2008 9:52:07 AM
More...
|
Greer Labs Announces Strategic Agreement with Axiom Veterinary Laboratories to Supply Allergy Immunotherapy Treatments to Veterinary Practices in the UK
10/22/2007 10:16:43 AM
More...
|
Greer Labs Granted Good Manufacturing Practices Compliance Certification from United Kingdom Veterinary Medicines Directorate
10/15/2007 12:14:21 PM
More...
|
Greer Labs Adds New Senior Research Scientist to its Source Materials Division
9/11/2007 11:37:37 AM
More...
|
Greer Labs Announces New Safety Syringe Contract with Inviro Medical
6/19/2007 1:58:47 PM
More...
|
|